子宫肌瘤治疗药物市场 - 按药物类别（黄体素释放子宫内避孕器、避孕药、促性腺激素释放激素拮抗剂）、类型（黏膜下、壁内）、配销通路、全球预测，2023-2032 年

从 2023 年到 2032 年，子宫肌瘤治疗药物市场规模预计将以 10% 的复合年增长率大幅成长。全球子宫肌瘤盛行率不断上升，引发了对有效药物干预措施的更高需求。

最近，人们越来越重视开发和提供先进的药物疗法，以有效控制症状并缩小肿瘤大小。根据妇女健康办公室的数据，20% 至 80% 的女性在 50 岁时会罹患肌瘤。因此，更加关註解决受影响个体的治疗需求已经为广泛的研发工作让路。此外，患者和医疗保健专业人员对可用治疗方案的认识不断提高也提振了产品需求。

子宫肌瘤治疗药物产业分为药物类别、类型、配销通路和区域。

按药物类别划分，促性腺激素释放激素拮抗剂细分市场的市场份额预计在2023 年至2032 年间将出现大幅增长。这可归因于促性腺激素释放激素(GnRH) 拮抗剂作为可行的非侵入性治疗选择的广泛使用。 GnRH 拮抗剂能够快速缓解症状并减轻月经出血量，因此越来越受到重视。有利的安全性和有限的副作用等好处将进一步促进该细分市场的成长。

医院配销通路​​领域的子宫肌瘤治疗药物行业在2022 年产生了可观的收入，预计到2032 年将强劲扩张。这种增长可归因于医院强大的基础设施和综合的患者护理方法，以确保有效的治疗和改善患者的状况结果。随着人们对微创手术的日益青睐，医院也越来越多地采用先进的药物解决方案来有效管理肌瘤。

从区域来看，由于医疗基础设施发展的激增、人们对子宫肌瘤的认识不断提高以及健康状况的患病率不断上升，预计到2032 年，亚太地区子宫肌瘤治疗药物行业将出现显着增长。微创手术的日益普及导致了针对该地区特定需求量身定制的新型药物解决方案的推出。

此外，旨在提高功效和尽量减少不利影响的持续研发活动将增强区域市场前景。举个例子，2022年7月，日本Kissei製药有限公司开始了GNRH拮抗剂林札戈利（KLH-2109）治疗子宫肌瘤的日本III期临床研究。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：子宫肌瘤治疗药物市场洞察

• 产业格局
• 产业影响力
  • 成长动力
    • 子宫肌瘤盛行率增加
    • 女性子宫肌瘤新药的开发
    • 人们对子宫肌瘤的认识不断提高
  • 产业陷阱与挑战
    • 与子宫肌瘤治疗药物相关的不良反应
• 成长潜力分析
• COVID-19 影响分析
• 监管环境
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 竞争定位矩阵
• 战略仪錶板

第 5 章：子宫肌瘤治疗药物市场估计与预测：按药物类别

• 主要动向：依药物类别
• 孕激素缓释子宫内避孕器 (IUD) 和避孕药具
• 促性腺激素释放激素 (GnRH) 拮抗剂
• 促性腺激素释放激素 (GnRH) 激动剂
• 非荷尔蒙药物
• 其他药物类别

第 6 章：子宫肌瘤治疗药物市场估计与预测：按类型

• 主要动向：依类型
• 黏膜下肌瘤
• 壁内肌瘤
• 浆膜下肌瘤
• 带蒂肌瘤

第 7 章：子宫肌瘤治疗药物市场估计与预测：按配销通路

• 主要动向：按配销通路
• 零售药局
• 医院药房
• 其他分销管道

第 8 章：子宫肌瘤治疗药物市场估计与预测：按地区

• 主要动向：按地区
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 瑞士
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 中东和非洲其他地区

第 9 章：公司简介

• Pfizer, Inc.
• Abbvie, Inc.
• AstraZeneca plc
• Bayer AG
• Myovant Sciences Gmbh
• Ferring B.V.
• Amring Pharmaceuticals Inc.
• Theramex
• Watson Pharma, Inc.

Uterine Fibroid Treatment Drugs Market size is set to witness substantial growth at 10% CAGR from 2023-2032. The escalating prevalence of uterine fibroids worldwide is triggering the heightened need for efficacious pharmaceutical interventions.

Of late, there has been growing emphasis on developing and providing advanced drug therapies to effectively manage symptoms and reduce tumor size. According to the Office on Women's Health, between 20% and 80% of women develop fibroids by the age of 50 years. Thus, the higher focus on addressing the therapeutic needs of affected individuals has made way for extensive R&D efforts. Moreover, the surging awareness among patients and healthcare professionals about available treatment options is also bolstering the product demand.

The uterine fibroid treatment drugs industry is segmented into drug class, type, distribution channel, and region.

By drug class, the market share from the gonadotropin-releasing hormone antagonist segment is set to witness considerable growth between 2023 and 2032. This can be attributed to the expanding utilization of gonadotropin-releasing hormone (GnRH) antagonists as viable non-invasive treatment options. With their ability to provide rapid symptomatic relief and alleviate heavy menstrual bleeding, GnRH antagonists are gaining significant prominence. Benefits, such as favorable safety profile and limited side effects will further contribute to the segment growth.

Uterine fibroid treatment drugs industry from the hospital distribution channel segment generated substantial revenue in 2022 and is expected to foresee robust expansion through 2032. The growth can be attributed to the robust infrastructure and integrated approach to patient care in hospitals for ensuring effective treatment and improved patient outcomes. With the growing preference for minimally invasive procedures, hospitals are also increasingly adopting advanced pharmaceutical solutions for effective fibroid management.

Regionally, the Asia Pacific uterine fibroid treatment drugs industry is projected to depict notable growth rate through 2032 fueled by the upsurge in healthcare infrastructure development, increasing awareness about uterine fibroids, and the rising prevalence of the health condition. The growing adoption of minimally invasive procedures has led to the introduction of novel pharmaceutical solutions tailored for specific needs in the region.

Moreover, the ongoing research and development activities aimed at enhancing the efficacy and minimizing adverse effects will augment the regional market outlook. To cite an instance, in July 2022, Japan-based Kissei Pharmaceutical Co., Ltd. began a Japanese Phase III clinical study for the GNRH antagonist linzagolix (KLH-2109) in uterine fibroids.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Covid-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Secondary
    • 1.6.1.1 Paid sources
    • 1.6.1.2 Public sources
  • 1.6.2 Primary

Chapter 2 Executive Summary

• 2.1 Uterine fibroid treatment drugs industry 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Region trends
  • 2.1.3 Drug class trends
  • 2.1.4 Type trends
  • 2.1.5 Distribution channel trends

Chapter 3 Uterine Fibroid Treatment Drugs Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of uterine fibroid
    • 3.2.1.2 Development of new drugs for women with uterine fibroids
    • 3.2.1.3 Growing awareness about uterine fibroids
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Adverse effects associated with uterine fibroid treatment drugs
• 3.3 Growth potential analysis
  • 3.3.1 By drug class
  • 3.3.2 By type
  • 3.3.3 By distribution channel
• 3.4 COVID-19 impact analysis
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive positioning matrix, 2022
• 4.4 Strategic dashboard, 2022

Chapter 5 Uterine Fibroid Treatment Drugs Market Estimates and Forecast, By Drug Class (USD Million)

• 5.1 Key trends, by drug class
• 5.2 Progestin-releasing intrauterine device (IUD) & contraceptives
• 5.3 Gonadotropin-releasing hormone (GnRH) antagonists
• 5.4 Gonadotropin-releasing hormone (GnRH) agonists
• 5.5 Non-hormonal medications
• 5.6 Other drug classes

Chapter 6 Uterine Fibroid Treatment Drugs Market Estimates and Forecast, By Type (USD Million)

• 6.1 Key trends, by type
• 6.2 Submucosal fibroids
• 6.3 Intramural fibroids
• 6.4 Subserosal fibroids
• 6.5 Pedunculated fibroids

Chapter 7 Uterine Fibroid Treatment Drugs Market Estimates and Forecast, By Distribution Channel (USD Million)

• 7.1 Key trends, by distribution channel
• 7.2 Retail pharmacies
• 7.3 Hospital pharmacies
• 7.4 Other distribution channels

Chapter 8 Uterine Fibroid Treatment Drugs Market Estimates and Forecast, By Region (USD Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Switzerland
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East & Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

• 9.1 Pfizer, Inc.
• 9.2 Abbvie, Inc.
• 9.3 AstraZeneca plc
• 9.4 Bayer AG
• 9.5 Myovant Sciences Gmbh
• 9.6 Ferring B.V.
• 9.7 Amring Pharmaceuticals Inc.
• 9.8 Theramex
• 9.9 Watson Pharma, Inc.

Data Tables

• TABLE 1 Product mapping
• TABLE 2 Market revenue, by drug class (2022)
• TABLE 3 Market revenue, by type (2022)
• TABLE 4 Market revenue, by distribution channel (2022)
• TABLE 5 Market share, by region (2022)
• TABLE 6 Global uterine fibroid treatment drugs market size, by region, 2018 - 2022 (USD Million)
• TABLE 7 Global uterine fibroid treatment drugs market size, by region, 2023 - 2032 (USD Million)
• TABLE 8 Global uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 9 Global uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 10 Global uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 11 Global uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 12 Global uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 13 Global uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 14 Industry impact forces
• TABLE 15 Competitive benchmarking of major market players
• TABLE 16 Competitive positioning matrix: Classification criteria
• TABLE 17 Strategic outlook matrix: Classification criteria
• TABLE 18 Progestin-releasing intrauterine device (IUD)& contraceptives market size, by region, 2018 - 2022 (USD Million)
• TABLE 19 Progestin-releasing intrauterine device (IUD)& contraceptives market size, by region, 2023 - 2032 (USD Million)
• TABLE 20 Gonadotropin-releasing hormone (GnRH) antagonists market size, by region, 2018 - 2022 (USD Million)
• TABLE 21 Gonadotropin-releasing hormone (GnRH) antagonists market size, by region, 2023 - 2032 (USD Million)
• TABLE 22 Gonadotropin-releasing hormone (GnRH) agonists market size, by region, 2018 - 2022 (USD Million)
• TABLE 23 Gonadotropin-releasing hormone (GnRH) agonists market size, by region, 2023 - 2032 (USD Million)
• TABLE 24 Non-hormonal medications market size, by region, 2018 - 2022 (USD Million)
• TABLE 25 Non-hormonal medications market size, by region, 2023 - 2032 (USD Million)
• TABLE 26 Other drug classes market size, by region, 2018 - 2022 (USD Million)
• TABLE 27 Other drug classes market size, by region, 2023 - 2032 (USD Million)
• TABLE 28 Submucosal fibroids market size, by region, 2018 - 2022 (USD Million)
• TABLE 29 Submucosal fibroids market size, by region, 2023 - 2032 (USD Million)
• TABLE 30 Intramural fibroids market size, by region, 2018 - 2022 (USD Million)
• TABLE 31 Intramural fibroids market size, by region, 2023 - 2032 (USD Million)
• TABLE 32 Subserosal fibroids market size, by region, 2018 - 2022 (USD Million)
• TABLE 33 Subserosal fibroids market size, by region, 2023 - 2032 (USD Million)
• TABLE 34 Pedunculated fibroids market size, by region, 2018 - 2022 (USD Million)
• TABLE 35 Pedunculated fibroids market size, by region, 2023 - 2032 (USD Million)
• TABLE 36 Retail pharmacies market size, by region, 2018 - 2022 (USD Million)
• TABLE 37 Retail pharmacies market size, by region, 2023 - 2032 (USD Million)
• TABLE 38 Hospital pharmacies market size, by region, 2018 - 2022 (USD Million)
• TABLE 39 Hospital pharmacies market size, by region, 2023 - 2032 (USD Million)
• TABLE 40 Other distribution channels market size, by region, 2018 - 2022 (USD Million)
• TABLE 41 Other distribution channels market size, by region, 2023 - 2032 (USD Million)
• TABLE 42 North America uterine fibroid treatment drugs market size, by country, 2018 - 2022 (USD Million)
• TABLE 43 North America uterine fibroid treatment drugs market size, by country, 2023 - 2032 (USD Million)
• TABLE 44 North America uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 45 North America uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 46 North America uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 47 North America uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 48 North America uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 49 North America uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 50 U.S. uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 51 U.S. uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 52 U.S. uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 53 U.S. uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 54 U.S. uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 55 U.S. uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 56 Canada uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 57 Canada uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 58 Canada uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 59 Canada uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 60 Canada uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 61 Canada uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 62 Europe uterine fibroid treatment drugs market size, by country, 2018 - 2022 (USD Million)
• TABLE 63 Europe uterine fibroid treatment drugs market size, by country, 2023 - 2032 (USD Million)
• TABLE 64 Europe uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 65 Europe uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 66 Europe uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 67 Europe uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 68 Europe uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 69 Europe uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 70 Germany uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 71 Germany uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 72 Germany uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 73 Germany uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 74 Germany uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 75 Germany uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 76 UK uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 77 UK uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 78 UK uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 79 UK uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 80 UK uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 81 UK uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 82 France uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 83 France uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 84 France uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 85 France uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 86 France uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 87 France uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 88 Spain uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 89 Spain uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 90 Spain uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 91 Spain uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 92 Spain uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 93 Spain uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 94 Italy uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 95 Italy uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 96 Italy uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 97 Italy uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 98 Italy uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 99 Italy uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 100 Switzerland uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 101 Switzerland uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 102 Switzerland uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 103 Switzerland uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 104 Switzerland uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 105 Switzerland uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 106 Rest of Europe uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 107 Rest of Europe uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 108 Rest of Europe uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 109 Rest of Europe uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 110 Rest of Europe uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 111 Rest of Europe uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 112 Asia Pacific uterine fibroid treatment drugs market size, by country, 2018 - 2022 (USD Million)
• TABLE 113 Asia Pacific uterine fibroid treatment drugs market size, by country, 2023 - 2032 (USD Million)
• TABLE 114 Asia Pacific uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 115 Asia Pacific uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 116 Asia Pacific uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 117 Asia Pacific uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 118 Asia Pacific uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 119 Asia Pacific uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 120 China uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 121 China uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 122 China uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 123 China uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 124 China uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 125 China uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 126 Japan uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 127 Japan uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 128 Japan uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 129 Japan uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 130 Japan uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 131 Japan uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 132 India uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 133 India uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 134 India uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 135 India uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 136 India uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 137 India uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 138 Australia uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 139 Australia uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 140 Australia uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 141 Australia uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 142 Australia uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 143 Australia uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 144 South Korea uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 145 South Korea uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 146 South Korea uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 147 South Korea uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 148 South Korea uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 149 South Korea uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 150 Rest of Asia Pacific uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 151 Rest of Asia Pacific uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 152 Rest of Asia Pacific uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 153 Rest of Asia Pacific uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 154 Rest of Asia Pacific uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 155 Rest of Asia Pacific uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 156 Latin America uterine fibroid treatment drugs market size, by country, 2018 - 2022 (USD Million)
• TABLE 157 Latin America uterine fibroid treatment drugs market size, by country, 2023 - 2032 (USD Million)
• TABLE 158 Latin America uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 159 Latin America uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 160 Latin America uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 161 Latin America uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 162 Latin America uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 163 Latin America uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 164 Brazil uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 165 Brazil uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 166 Brazil uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 167 Brazil uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 168 Brazil uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 169 Brazil uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 170 Mexico uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 171 Mexico uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 172 Mexico uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 173 Mexico uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 174 Mexico uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 175 Mexico uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 176 Rest of Latin America uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 177 Rest of Latin America uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 178 Rest of Latin America uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 179 Rest of Latin America uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 180 Rest of Latin America uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 181 Rest of Latin America uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 182 Middle East & Africa uterine fibroid treatment drugs market size, by country, 2018 - 2022 (USD Million)
• TABLE 183 Middle East & Africa uterine fibroid treatment drugs market size, by country, 2023 - 2032 (USD Million)
• TABLE 184 Middle East & Africa uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 185 Middle East & Africa uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 186 Middle East & Africa uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 187 Middle East & Africa uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 188 Middle East & Africa uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 189 Middle East & Africa uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 190 South Africa uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 191 South Africa uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 192 South Africa uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 193 South Africa uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 194 South Africa uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 195 South Africa uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 196 Saudi Arabia uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 197 Saudi Arabia uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 198 Saudi Arabia uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 199 Saudi Arabia uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 200 Saudi Arabia uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 201 Saudi Arabia uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)
• TABLE 202 Rest of Middle East & Africa uterine fibroid treatment drugs market size, by drug class, 2018 - 2022 (USD Million)
• TABLE 203 Rest of Middle East & Africa uterine fibroid treatment drugs market size, by drug class, 2023 - 2032 (USD Million)
• TABLE 204 Rest of Middle East & Africa uterine fibroid treatment drugs market size, by type, 2018 - 2022 (USD Million)
• TABLE 205 Rest of Middle East & Africa uterine fibroid treatment drugs market size, by type, 2023 - 2032 (USD Million)
• TABLE 206 Rest of Middle East & Africa uterine fibroid treatment drugs market size, by distribution channel, 2018 - 2022 (USD Million)
• TABLE 207 Rest of Middle East & Africa uterine fibroid treatment drugs market size, by distribution channel, 2023 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: Critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Uterine fibroid treatment drugs industry 360 degree synopsis, 2018 - 2032
• FIG 7 Growth potential analysis, by drug class
• FIG 8 Growth potential analysis, by type
• FIG 9 Growth potential analysis, by distribution channel
• FIG 10 Porter's analysis
• FIG 11 PESTEL analysis
• FIG 12 Company matrix analysis, 2022
• FIG 13 Competitive positioning matrix, 2022
• FIG 14 Strategic dashboard, 2022